Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

FDA approves Celcuity's Revtorpyk (gedatolisib) for PI3K pathway hormone receptor-positive, HER2-negative metastatic breast cancer after Ph3 success
Small molecule, cancer, kinase inhibitor, breast cancer, PI3K/AKT pathway, HR-positive HER2-negative - Read more

Sanofi's immunomodulatory therapy wins UAE approval to delay Type 1 diabetes onset in children aged one and older
Antibody, autoimmune, monoclonal antibody, type 1 diabetes, beta cell preservation, pediatric - Read more

Insilico Medicine, Bora Pharmaceuticals partner on AI drug discovery and commercialization, deal worth $2.5B
Co-development, AI/ML, drug discovery, manufacturing, milestone payments - Read more

Whether you’re working in genomics, imaging, or research, the key to innovation is fast, seamless access to your data–anywhere you need it. 

Qumulo Cloud Data Fabric unifies distributed data into a single global namespace, enabling teams to collaborate and access the same data from anywhere. 

Learn how Qumulo is putting infrastructure at the cutting edge of pharma and medical research. Explore the solution here.

Huyabio's HBI-8000 (tucidinostat) combo with Bristol Myers Squibb's Opdivo (nivolumab) meets Ph3 primary endpoint in advanced melanoma
Small molecule, cancer, HDAC inhibitor, melanoma, combination therapy, Opdivo - Read more

Kelun-Biotech's (sacituzumab tirumotecan) plus Merck & Co.'s Keytruda meets primary endpoint in Ph3 for PD-L1-negative non-squamous non-small cell lung cancer
Antibody drug conjugate, cancer, non-small cell lung cancer, TROP2, combination therapy, pembrolizumab - Read more

BPGbio reports encouraging Ph2 data for BPM31510 (oxidized CoQ10) targeting mitochondrial metabolism in newly diagnosed glioblastoma multiforme
Small molecule, cancer, glioblastoma, mitochondrial therapy, combination therapy, MGMT unmethylated - Read more

Attovia Therapeutics files for IPO of undisclosed amount, advancing IL-31 inhibitor challenging Dupixent
Biologics, autoimmune, atopic dermatitis, clinical-stage, bispecific antibody - Read more

Lyora Therapeutics raises $2.5M Pre-Seed funding, developing genetic medicines for inherited retinal diseases
Genetic medicine, inherited retinal disease, CRISPR, gene therapy, rare disease, preclinical - Read more

Cardiff Oncology plans $10M registered direct offering for working capital and general corporate purposes
Oncology, clinical-stage, small molecule, PLK1 inhibition - Read more

Q32 Bio prices $200M public offering to advance bempikibart clinical trials, autoimmune diseases
Clinical-stage, autoimmune, inflammatory disease, alopecia areata, antibody - Read more

Crescent Biopharma prices ~$125M public offering of ordinary shares and pre-funded warrants
Clinical-stage, oncology, cancer - Read more

GSK completes acquisition of Nuvalent, adding three lung cancer assets with multi-blockbuster potential
Small molecule, oncology, major transaction, strategic - Read more

Taiho Pharmaceutical launches PI3Kα inhibitor HAIZEXIN in Japan for PIK3CA-mutant ovarian cancer
Small molecule, oncology, regulatory, strategic - Read more

NICE backs Bayer's finerenone for chronic heart failure patients in England and Wales
Small molecule, cardiovascular, regulatory, revenue impact - Read more

FDA grants priority review to Genentech's Gazyva (obinutuzumab) for primary membranous nephropathy based on Ph3 results
Antibody, autoimmune, monoclonal antibody, primary membranous nephropathy, CD20 target, B cell depletion - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Apple Tree Partners loses fund control as Cayman court orders Seth Harrison to relinquish management oversight
Venture capital, biotechnology, financial, operational - Read more

Community Pharmacy England warns 75% of pharmacies losing money as medicine shortages impact patients daily
Pharmacy services, medicine shortages, operational, financial - Read more

FDA resumes releasing drug rejection letters after April pause, addressing redaction concerns
Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here